Morgan Stanley Reiterates Overweight on Molina Healthcare, Maintains $365 Price Target
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Ricky Goldwasser has reiterated an Overweight rating on Molina Healthcare (NYSE:MOH) and maintained a price target of $365.
July 14, 2023 | 3:07 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Molina Healthcare's stock rating has been reiterated as Overweight by Morgan Stanley, with a maintained price target of $365.
The reiteration of an Overweight rating by a major financial institution like Morgan Stanley indicates a positive outlook for Molina Healthcare. The maintained price target of $365 suggests that the analyst believes the stock has potential for growth. This could lead to increased investor confidence and potentially a rise in stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100